Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (351-360 of 437) with videos related to

Pageof 44
Sort By:
Blood Advances|May 9, 2020
Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosisMatthias Felber, Colin G Steward, Karim Kentouche, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 24, 2015
Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young childrenBeate Hagl, Valerie Heinz, Anne Schlesinger, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.
The Journal of Allergy and Clinical Immunology|February 6, 2013
Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiencyMelissa C Mizesko, Pinaki P Banerjee, Linda Monaco-Shawver, et al.
British Journal of Haematology|July 21, 2018
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trialMichaela Kuhlen, Peter Bader, Martin Sauer, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Bone Marrow Transplantation|February 14, 2023
Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working PartySu Han Lum, Milen Minkov, Simon A Jones, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2019
Increased proportions of γδ T lymphocytes in atypical SCID associate with disease manifestationsInga Tometten, Kerstin Felgentreff, Manfred Hönig, et al.
Pageof 44

Showing results (351-360 of 437) with videos related to

Sort By:
Pageof 44
Blood Advances|May 9, 2020
Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosisMatthias Felber, Colin G Steward, Karim Kentouche, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 24, 2015
Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young childrenBeate Hagl, Valerie Heinz, Anne Schlesinger, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.
The Journal of Allergy and Clinical Immunology|February 6, 2013
Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiencyMelissa C Mizesko, Pinaki P Banerjee, Linda Monaco-Shawver, et al.
British Journal of Haematology|July 21, 2018
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trialMichaela Kuhlen, Peter Bader, Martin Sauer, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Bone Marrow Transplantation|February 14, 2023
Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working PartySu Han Lum, Milen Minkov, Simon A Jones, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2019
Increased proportions of γδ T lymphocytes in atypical SCID associate with disease manifestationsInga Tometten, Kerstin Felgentreff, Manfred Hönig, et al.
Pageof 44